Financhill
Sell
25

BPMC Quote, Financials, Valuation and Earnings

Last price:
$89.89
Seasonality move :
2.18%
Day range:
$88.70 - $90.99
52-week range:
$72.24 - $121.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
13.04x
P/B ratio:
18.32x
Volume:
321.3K
Avg. volume:
639.2K
1-year change:
1.69%
Market cap:
$5.7B
Revenue:
$249.4M
EPS (TTM):
-$2.11

Blueprint Medicines SEC Filings

Company Filed Form Type Description
BPMC
Blueprint Medicines
10/26/2023 10-Q 10-Q filing on 10/26/2023 View Form
BPMC
Blueprint Medicines
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
BPMC
Blueprint Medicines
05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
BPMC
Blueprint Medicines
11/01/2022 10-Q 10-Q filing on 11/01/2022 View Form
BPMC
Blueprint Medicines
08/02/2022 10-Q 10-Q filing on 08/02/2022 View Form
BPMC
Blueprint Medicines
05/03/2022 10-Q 10-Q filing on 05/03/2022 View Form
BPMC
Blueprint Medicines
10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
BPMC
Blueprint Medicines
07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
BPMC
Blueprint Medicines
04/29/2021 10-Q 10-Q filing on 04/29/2021 View Form
BPMC
Blueprint Medicines
10/29/2020 10-Q 10-Q filing on 10/29/2020 View Form
BPMC
Blueprint Medicines
07/31/2020 10-Q 10-Q filing on 07/31/2020 View Form
BPMC
Blueprint Medicines
07/30/2020 10-Q 10-Q filing on 07/30/2020 View Form
BPMC
Blueprint Medicines
05/06/2020 10-Q 10-Q filing on 05/06/2020 View Form
BPMC
Blueprint Medicines
02/13/2020 10-K 10-K filing on 02/13/2020 View Form
BPMC
Blueprint Medicines
11/05/2019 10-Q 10-Q filing on 11/05/2019 View Form
BPMC
Blueprint Medicines
08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
BPMC
Blueprint Medicines
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
BPMC
Blueprint Medicines
02/26/2019 10-K 10-K filing on 02/26/2019 View Form
BPMC
Blueprint Medicines
10/30/2018 10-Q 10-Q filing on 10/30/2018 View Form
BPMC
Blueprint Medicines
08/01/2018 10-Q 10-Q filing on 08/01/2018 View Form
BPMC
Blueprint Medicines
08/01/2018 10-K 10-K filing on 08/01/2018 View Form
BPMC
Blueprint Medicines
05/02/2018 10-Q 10-Q filing on 05/02/2018 View Form
BPMC
Blueprint Medicines
02/21/2018 10-K 10-K filing on 02/21/2018 View Form
BPMC
Blueprint Medicines
10/31/2017 10-Q 10-Q filing on 10/31/2017 View Form
BPMC
Blueprint Medicines
08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
BPMC
Blueprint Medicines
05/03/2017 10-Q 10-Q filing on 05/03/2017 View Form
BPMC
Blueprint Medicines
03/09/2017 10-K 10-K filing on 03/09/2017 View Form
BPMC
Blueprint Medicines
11/10/2016 10-Q 10-Q filing on 11/10/2016 View Form
BPMC
Blueprint Medicines
08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
BPMC
Blueprint Medicines
07/22/2016 10-Q 10-Q filing on 07/22/2016 View Form
BPMC
Blueprint Medicines
05/10/2016 10-Q 10-Q filing on 05/10/2016 View Form
BPMC
Blueprint Medicines
03/11/2016 10-K 10-K filing on 03/11/2016 View Form
BPMC
Blueprint Medicines
11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
BPMC
Blueprint Medicines
08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form
BPMC
Blueprint Medicines
06/11/2015 10-Q 10-Q filing on 06/11/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is up 8.33% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is down 0.76% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is down 0.77% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock